Related Experiment Video
Updated: Oct 19, 2025
05:21
In Vivo Confocal Microscopy: A Standard Operating Procedure for the Detection of Demodex Mites at the Eyelid Margin
Published on: July 3, 2025
408
Different Approach to Manage Demodex Blepharitis - Initial and Maintenance Treatment
Christina Jacobi1,2, Serge Doan3, Viktoria Pavel4
1Ophthalmology Private Practice, Nuremberg, Germany.
Current Eye Research
|September 27, 2021
Summary
This study shows that daily eyelid wipes with terpinen-4-ol (T4O) significantly improve Demodex blepharitis symptoms within four weeks. Continued use of maintenance wipes preserves or enhances these positive outcomes, with good tolerability.
Area of Science:
- Ophthalmology
- Dermatology
- Microbiology
Background:
- Demodex blepharitis is a common condition causing ocular discomfort and inflammation.
- Effective treatment strategies are needed to manage Demodex mite infestation and associated symptoms.
Purpose of the Study:
- To evaluate the efficacy of a combined treatment for Demodex blepharitis using terpinen-4-ol (T4O) and hyaluronic acid (HA) wipes.
- To assess the maintenance of treatment effects with eyelid cleansing wipes after initial therapy.
Main Methods:
- Fifty patients with Demodex blepharitis received daily T4O-impregnated wipes for 28 days.
- A subsequent 28-day maintenance period involved either maintenance wipes or continued T4O wipes.
- Ocular signs, symptoms, and patient-reported outcomes were assessed at days 28 and 56.
Main Results:
- Significant improvement in ocular discomfort, blepharitis symptoms, and investigator-assessed signs after 28 days of T4O treatment.
- Treatment effects were maintained or improved during the maintenance period.
- Both treatment regimens were well-tolerated with no adverse events.
Conclusions:
- Daily T4O eyelid wipes are effective in improving ocular symptoms and signs of Demodex blepharitis within four weeks.
- Maintenance therapy with eyelid wipes sustains or enhances treatment success.
- The combined approach offers a well-tolerated and convenient treatment option.
Related Concept Videos
01:27Open Angle Glaucoma: Treatment
755
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
755
01:28Angle Closure Glaucoma: Treatment
889
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
889
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
686
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
686
01:26COPD: Management Using Bronchodilators and Corticosteroids
478
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
478
01:19Management of Insomnia
341
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
341
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.8K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.8K